Treatment for: Anemia Associated with Chronic Renal Failure FDA Provides Akebia Therapeutics a Path Forward for Vadadustat CAMBRIDGE, Mass., May
Lifileucel
Treatment for: Melanoma Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for
Xphozah
Generic name: tenapanor Treatment for: Hyperphosphatemia of Renal Failure Ardelyx Resubmits New Drug Application to U.S. Food and Drug Administration
Needleman innovation program seeks proposals for therapeutic development
The newly established Needleman Program for Innovation and Commercialization at Washington University School of Medicine in St. Louis is seeking
